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Abstract
 
CD4
 
 
 
 T cells are positively selected in the thymus on peptides presented in the context of ma-
jor histocompatibility complex class II molecules expressed on cortical thymic epithelial cells.
Molecules regulating this peptide presentation play a role in determining the outcome of posi-
tive selection. Cathepsin L mediates invariant chain processing in cortical thymic epithelial
cells, and animals of the I-A
 
b
 
 haplotype deficient in this enzyme exhibit impaired CD4
 
 
 
 T cell
selection. To determine whether the selection defect is due solely to the block in invariant
chain cleavage we analyzed cathepsin L–deficient mice expressing the I-A
 
q
 
 haplotype which
has little dependence upon invariant chain processing for peptide presentation. Our data indi-
cate the cathepsin L defect in CD4
 
 
 
 T cell selection is haplotype independent, and thus imply
it is independent of invariant chain degradation. This was confirmed by analysis of I-A
 
b
 
 mice
deficient in both cathepsin L and invariant chain. We show that the defect in positive selection
in the cathepsin L
 
 
 
/
 
 
 
 thymus is specific for CD4
 
 
 
 T cells that can be selected in a wild-type
and provide evidence that the repertoire of T cells selected differs from that in wild-type mice,
suggesting cortical thymic epithelial cells in cathepsin L knockout mice express an altered pep-
tide repertoire. Thus, we propose a novel role for cathepsin L in regulating positive selection
by generating the major histocompatibility complex class II bound peptide ligands presented by
cortical thymic epithelial cells.
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Introduction
 
The diversity of the peripheral T cell repertoire is deter-
mined in the thymus by positive and negative selection,
two events affected primarily by distinct APCs (1). Cortical
thymic epithelial cells (cTECs)
 
*
 
 mediate positive selection
of thymocytes expressing a TCR with low avidity for
peptide–MHC class II complexes. Negative selection of
potentially autoreactive T cells with high avidity for pep-
tide–MHC class II complexes is induced by bone marrow–
derived APCs. The interaction of the TCR with the MHC
class II–peptide complex is central to both positive and
negative selection, and therefore, the make-up of the thy-
mic MHC class II peptide repertoire plays a key role in de-
termining whether or not a T cell is selected (2, 3). Load-
ing of peptide into the MHC class II peptide binding
groove is tightly regulated, and requires that degradation of
Ag and maturation of MHC class II occurs in the same or
interconnected intracellular compartments (4, 5). Thus, the
cellular proteins involved in these processes impact the thy-
mic MHC class II peptide repertoire and hence CD4
 
 
 
 T
cell selection.
MHC class II heterodimers are assembled in the endo-
plasmic reticulum with the assistance of the chaperone
molecule invariant chain (Ii) (6, 7). The class II–associated
Ii peptide (CLIP) region of Ii interacts with the MHC class
II peptide binding groove to prevent inappropriate peptide
loading (8, 9) and signals in the cytoplasmic tail of Ii target
the Ii–MHC class II complex to the endosomal pathway
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Abbreviations used in this paper:
 
 A
 
 
 
 
 
/
 
 
 
, MHC class II–deficient mice;
BL6, C57BL/6; catL, cathepsin L; catS, cathepsin S; CLIP, class II–associ-
ated Ii peptide; cTEC, cortical thymic epithelial cell; HRP, horseradish
peroxidase; Ii, invariant chain; RAG, recombination-activating gene. 
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(10, 11). Entry of the Ii–MHC class II complex into the
endocytic pathway exposes Ii to endosomal proteases
known as cathepsins (12, 13). Cathepsins degrade Ii in a
step-wise manner, leaving CLIP associated with the MHC
class II heterodimer. Cathepsins have also been implicated
in generation of the antigenic peptide fragments presented
in the context of MHC class II molecules (14–17), al-
though the extent to which individual enzymes play a role
in this process in different APCs remains to be defined. Ex-
change of CLIP for this diverse array of peptides is cata-
lyzed by the MHC class II–like protein HLA-DM (H-2M
in mice; 18–20) and precedes transport of the peptide–
MHC class II complex to the cell surface.
Recent studies in knockout animals have shown that the
lysosomal cysteine proteases cathepsin S (catS) and cathep-
sin L (catL) are differentially expressed and play an impor-
tant role in MHC class II presentation by discrete popula-
tions of APCs (21–24). CatL activity is detected in cTECs,
catS activity is observed in B cells and dendritic cells while
both enzymes are expressed by macrophages. Analysis of
distinct subsets of APCs from catS
 
 
 
/
 
 
 
 and catL
 
 
 
/
 
 
 
 animals
indicated these enzymes mediate the late stages of Ii degra-
dation and are critical for presentation of peptide in the
context of MHC class II (21, 23, 24). In catL
 
 
 
/
 
 
 
 mice the
MHC class II presentation defect results in severely im-
paired selection of CD4
 
 
 
 T cells (21) and has thus far been
interpreted to be due to the critical role played by catL in Ii
cleavage. However, it is difficult to determine whether
catL is also directly involved in other processes impacting
MHC class II presentation, e.g., epitope generation or ac-
cessory molecule degradation, as presentation of peptides in
the context of I-A
 
b
 
 molecules is severely impaired by Ii de-
fects (25, 26). To circumvent this problem, in the studies
described here, we used mice deficient in both catL and Ii
to determine whether catL impacts MHC class II presenta-
tion independently of its effect on Ii processing.
Studies comparing mice deficient in both Ii and H-2M
with Ii single knockout animals have shown that there is a
substantial decrease in the number of CD4
 
 
 
 T cells selected
if the diversity and level of expression of endogenous pep-
tide–MHC class II complexes is significantly reduced (3,
27–29). By measuring CD4
 
 
 
 T cell numbers in catL-defi-
cient mice, we have analyzed the role played by catL in
generating the positively selecting cTEC MHC class II
peptide epitopes. We show that catL is required to mediate
efficient positive selection of MHC class II restricted TCR
transgenic thymocytes and that CD4
 
 
 
 T cell selection is
impaired equally in catL deficient mice of both the I-A
 
b
 
 (Ii
degradation dependent) and I-A
 
q
 
 haplotype (Ii degradation
independent). Most significantly, we demonstrate that in
animals deficient in both catL and Ii the low level of CD4
 
 
 
T cell selection observed in catL and Ii single knockout an-
imals is further reduced, almost to the background level de-
tected in MHC class II–deficient animals. These results in-
dicate a role for catL in MHC class II presentation that is
independent of its effect on Ii cleavage. We further provide
evidence to suggest that positive selection of an altered T
cell repertoire occurs in the absence of catL, and thus we
 
hypothesize this enzyme is involved in generating the posi-
tively selecting peptide ligands in cTECs.
 
Materials and Methods
 
Mice.
 
C57BL/6 (BL6), DBA/1, recombination-activating
gene (RAG)
 
 
 
/
 
 
 
, and MHC class II–deficient mice (A
 
 
 
 
 
/
 
 
 
) were
purchased from The Jackson Laboratory and maintained under
specific pathogen-free conditions at the University of Washing-
ton. CatL
 
 
 
/
 
 
 
 (H-2
 
b
 
; reference 21), Ii
 
 
 
/
 
 
 
 on a BL6 background
(purchased from The Jackson Laboratory), and the TCli (30) and
OT-1 (provided by M. Bevan, University of Washington) TCR
transgenics, were all bred and maintained under these same con-
ditions. The TCR transgenic mice used in these studies were all
maintained on a homozygous RAG
 
 
 
/
 
 
 
 background. RAG
 
 
 
/
 
 
 
Ii
 
 
 
/
 
 
 
 mice were generated by breeding RAG
 
 
 
/
 
 
 
 and Ii
 
 
 
/
 
 
 
 ani-
mals. CatL
 
 
 
/
 
 
 
Ii
 
 
 
/
 
 
 
 double knockout mice were generated by
crossing catL
 
 
 
/
 
 
 
 and Ii
 
 
 
/
 
 
 
 animals. CatL
 
 
 
/
 
 
 
 (H-2
 
q
 
) animals were
generated by breeding catL
 
 
 
/
 
 
 
 (H-2
 
b
 
) mice onto a DBA/1 back-
ground. All procedures and care of the animals was in accordance
with University of Washington guidelines.
 
Antibodies.
 
The following antibodies directed toward mouse
cell surface antigens were purchased from BD PharMingen:
FITC-conjugated anti-CD4, FITC-conjugated anti-V
 
 
 
5, FITC-
conjugated anti-CD11c, PE-conjugated anti-CD8
 
 
 
, PE-conju-
gated anti-V
 
 
 
6, PE-conjugated BP-1, PerCP-conjugated anti-CD4.
Horseradish peroxidase (HRP)-conjugated donkey anti–rabbit
IgG was purchased from Amersham Pharmacia Biotech and
HRP-conjugated mouse anti–rat IgG was purchased from Accu-
rate Chemical and Scientific Corp. The polyclonal rabbit antise-
rum to mouse catL was a gift of A. Erickson (University of North
Carolina at Chapel Hill, Chapel Hill, NC). IN-1 (anti-Ii), M5/114
(anti-I-A
 
b,d,q
 
, anti-E
 
d,k
 
), and biotin conjugated Y3P (anti-I-A
 
b
 
)
have been described previously (21, 23, 31–33).
 
Bone Marrow Chimeras.
 
Bone marrow cells were obtained
from the femoral and tibial bone donors, pooled and washed
with supplemented RPMI. T cells were depleted by incubating
the cells in a 1:1 mixture of anti-CD4 (GK1.5) and anti-CD8
(3.168.8) Ab supernatants, followed by treatment with low-toxin
rabbit complement (Cedarlane). The cells were washed in sup-
plemented RPMI, resuspended in PBS at the required cell den-
sity, and 0.2 ml cell suspension was injected intravenously into
the recipient. Host animals were administered a lethal dose of ir-
radiation (950 rads) 24 h before bone marrow transplantation.
Mice were maintained on water containing neomycin (25 
 
 
 
g/
ml) and polymyxin B (13 
 
 
 
g/ml) from irradiation until the ex-
periment was terminated. Mice were killed for analysis 6–8 wk
after bone marrow transplantation.
 
Enrichment for cTECs and Flow Cytometry.
 
Enrichment for cTECs
was performed as described previously (21). Briefly, thymi from
6–8-wk-old mice were mechanically disrupted and dissociated
with an enzyme mixture containing collagenase (1 mg/ml), dis-
pase (1 mg/ml), and DNase1 (50 
 
 
 
g/ml; all Roche Molecular
Biochemicals). The cell suspension was further enriched for
cTECs by centrifugation over a discontinuous Percoll gradient.
Low density fractions were harvested and cTECs identified by
flow cytometry as BP-1
 
hi
 
CD11c
 
 
 
CD4
 
 
 
.
The cell surface phenotype of splenocytes, thymocytes, and
cTECs from chimeric and knockout animals was determined by
four color flow cytometry. Single cell suspensions were depleted
of erythrocytes and 
 
 
 
1 
 
 
 
 10
 
6
 
 cells were incubated in the pres-
ence of conjugated antibodies. Binding of biotin conjugated anti-
bodies was detected by allophycocyanin-conjugated streptavidin 
1351
 
Honey et al.
 
(BD PharMingen). Data was collected using a FACSCalibur™
flow cytometer (Becton Dickinson) and analyzed using CELL
Quest™ software (Becton Dickinson). Typically 50,000 events
were recorded for splenocyte analysis and 100,000 events for thy-
mocyte and cTEC analysis.
 
Immunoblotting and Immunoprecipitation.
 
Thymic stroma was
washed in PBS and lysed in cell lysis buffer (0.5% NP-40, 0.15 M
NaCl, 5 mM EDTA, 50 mM Tris-HCl, pH 7.2) supplemented
with a cocktail of protease inhibitors (Roche Molecular Biochem-
icals). Debris was removed by centrifugation at 8,000 rpm for 10
min and the lysates analyzed for protein content using Coo-
massie
 
®
 
 Plus Protein Assay Reagent (Pierce Chemical Co.). Ly-
sate samples containing the indicated amount of total protein were
boiled for 5 min in SDS-reducing buffer and separated by 12%
SDS-PAGE. The proteins were electrophoretically transferred
onto nitrocellulose membrane and this was probed using the indi-
cated primary Ab. Binding was detected using the appropriate
HRP-conjugated secondary Ab diluted 1:1,500 and visualized by
chemiluminescence (ECL; Amersham Pharmacia Biotech).
For immunoprecipitation, thymic stroma was lysed in 1% NP-
40, 0.01 M Tris pH 7.3, 0.15 M NaCl supplemented with a cock-
tail of protease inhibitors and then assayed for protein content, as
described above. Lysate aliquots containing 100 
 
 
 
g of total pro-
tein were precleared with protein G-sepharose (Amersham Phar-
macia Biotech) and with 18 
 
 
 
g normal rat IgG (Caltag Laborato-
ries Inc.) before precipitation of MHC class II molecules using the
Ab M5/114. Precipitated proteins were boiled in SDS-reducing
buffer, separated by 12% SDS-PAGE, transferred electrophoreti-
cally onto nitrocellulose, and immunoblotted as described above.
 
Cysteine Protease Active Site Labeling.
 
Thymic stromal lysate
aliquots, prepared as described above, containing 100 
 
 
 
g total
protein were incubated for 2 h at 37
 
 
 
C in the presence of 0.25
 
 
 
M cysteine protease inhibitor Bio-Tyr-Ala-FMK. This biotiny-
lated inhibitor is an analogue of the previously described Cbz-
 
125
 
I-Tyr-Ala-CN
 
2
 
 (34) and it binds irreversibly to the active site
cysteine of the enzyme via a thioester bond. Lysates were boiled
in SDS-reducing buffer, separated by 12% SDS-PAGE, trans-
ferred onto nitrocellose, and immunoblotted as described above,
using streptavidin-conjugated HRP.
 
Results
 
Selection of CD4
 
 
 
 But Not CD8
 
 
 
 T Cell Receptor Trans-
genic T Cells Is Impaired in Cathepsin L–deficient Mice.
 
We have
shown previously that cTEC expression of catL is required
for efficient selection of CD4
 
 
 
 T cells (21). Furthermore,
we suggested that the defect in CD4
 
 
 
 T cell selection in
catL
 
 
 
/
 
 
 
 mice was due to expression of an altered MHC
class II peptide repertoire by cTECs in these animals.
However, it remained possible that this defect in selection
was less specific and was a result of a global suppression of
the positively selecting thymic environment. To address
this possibility we sought to determine whether the effect
of catL deficiency on selection was restricted to the devel-
opment of CD4
 
 
 
 T cells, or whether CD8
 
 
 
 T cell matura-
tion was also impaired.
We transferred bone marrow from either a MHC class
II–restricted TCR transgenic mouse (TCli) or a MHC class
I–restricted TCR transgenic mouse (OT-1) into lethally ir-
radiated catL
 
 
 
/
 
 
 
 or wild-type mice. The TCR transgenic
donors were on a RAG
 
 
 
/
 
 
 
 background to prevent endog-
enous 
 
 
 
-chain rearrangement during selection. Chimerism
was 
 
 
 
92% in all animals analyzed (data not shown). Analy-
sis of splenocytes and thymocytes from TCli bone marrow
recipients indicated that selection of the transgenic T cells
(CD4
 
 
 
 V
 
 
 
6
 
 
 
) was almost completely abrogated in catL de-
ficient recipients (Fig. 1 A). Selection of OT-1 TCR trans-
genic T cells (CD8
 
 
 
 V
 
 
 
5
 
 
 
), however, occurred normally
in catL
 
 
 
/
 
 
 
 hosts (Fig. 1 B). This observation that transgenic
CD4
 
 
 
 T cells cannot be positively selected by the catL-
deficient thymic environment while selection of CD8
 
 
 
 T
cells is not impaired, indicates that catL is not essential for
maintenance of a viable positive selection environment but
that its effect is specific for CD4
 
 
 
 T cells. Thus, this result
suggests the MHC class II peptide repertoire expressed at
the surface of catL
 
 
 
/
 
 
 
 cTECs is altered such that it cannot
Figure 1. Impaired selection
of CD4  but not CD8  T cell
receptor transgenic T cells in
cathepsin L–deficient mice. Bone
marrow isolated from either
CD4  TCR transgenic (TCli) or
CD8  TCR transgenic (OT-1)
mice was transplanted into le-
thally irradiated catL /  and BL6
mice. The spleen and thymus of
chimeric mice were analyzed by
flow cytometry 8 wk after bone
marrow transplantation. The
percentage of donor T cells was
determined by CD4  V  6 
staining for TCli recipients (A)
and CD8  V  5  staining for
OT-1 recipients (B). The data
shown are representative of three
independent experiments with
two to three mice per group.1352 Regulation of CD4 T Cell–positive Selection by Cathepsin L
support efficient selection of CD4  T cells that develop in
wild-type mice.
If the MHC class II peptide repertoire of cTECs is al-
tered by the absence of catL, one may predict that an al-
tered T cell repertoire would be positively selected, and
then subjected to extensive negative selection on the nor-
mal MHC class II peptide repertoire expressed on the sur-
face of bone marrow–derived APCs, thereby resulting in
decreased CD4  T cell selection. We sought to investigate
this possibility by transplanting lethally irradiated catL / 
mice and BL6 controls with either BL6 or A  /  bone
marrow. Analysis of chimeric animals indicated the per-
centage of CD4 single-positive thymocytes in (A  /  →
BL6) mice was 2–3-fold greater than in (BL6 → BL6) chi-
meras, while (A  /  → catL / ) mice exhibited a 5–15-
fold increase over (BL6 → catL / ) chimeras (Fig. 2). The
relative increase in the percentage of CD4 single-positive
thymocytes in A  /  bone marrow recipients, when com-
pared with BL6 recipients, correlates directly with the pro-
portion of MHC class II–restricted thymocytes undergoing
negative selection (35). Therefore, our observation that
CD4 single-positive thymocyte accumulation is enhanced
in (A  /  →  catL / ) mice compared with (A  /  →
BL6) controls implies that the degree of negative selection
in catL-deficient animals is substantially greater than in
wild-type mice. This result suggests that the MHC class II
peptide repertoire of catL /  mice elicits positive selection
of an altered T cell repertoire and thus, further supports our
hypothesis that the MHC class II peptide repertoire is al-
tered in the absence of catL.
CD4  T Cell Selection Is Impaired in H-2q Cathepsin
L–deficient Mice. The observation that selection of CD4 
TCR transgenic thymocytes is severely impaired in catL / 
hosts provides strong evidence that the MHC class II pep-
tide repertoire of cTECs is significantly altered in these an-
imals. This altered peptide repertoire of catL deficient
cTECs may be a result of the large number of I-Ab mole-
cules associated with p12 Ii fragments that accumulate in
the absence of catL (21). Alternatively, catL may play a di-
rect role in generating the peptide epitopes involved in
positive selection of CD4  T cells. The accumulation of
p12 Ii fragments associated with MHC class II in bone
marrow–derived APCs from catS-deficient mice is haplo-
type dependent, as these complexes are readily detected in
I-Ab but not I-Aq catS /  animals (23). This correlates with
the observation that presentation of several protein Ags is
impaired in I-Ab but not I-Aq catS deficient mice (23) and
indicates that the role of catS in regulating presentation of
these peptides is mediated via its effect on Ii processing.
Thus, the dependence of MHC class II peptide presenta-
tion on Ii degradation exhibits haplotype variance in bone
marrow–derived APCs. We therefore sought to determine
whether a similar difference in the extent of p12 Ii frag-
ment association with MHC class II of the I-Ab and I-Aq
haplotypes existed in cTECs isolated from catL /  mice.
Thymic stromal cell lysates from I-Ab and I-Aq catL / ,
catL / , and catL /  animals were analyzed by immuno-
precipitation with the anti-I-Ab,d,q Ab M5/114 and subse-
quent immunoblotting with the Ii-specific Ab IN-1 (Fig. 3
A). Thymic stroma from Ii-deficient animals was used as a
negative control. The level of MHC class II association
with p12 Ii fragments was substantially greater for the I-Ab
haplotype than the I-Aq haplotype, both in wild-type and
catL deficient animals (Fig. 3 A). Reprobing the immuno-
blot with rabbit anti-sera specific for the cytoplasmic tails of
the MHC class II   and   chains indicated equivalent
amounts of I-Ab and I-Aq had been precipitated (data not
shown). These observations indicate cTECs exhibit the
same difference in haplotype dependence upon Ii degrada-
tion as has previously been reported for bone marrow de-
rived APCs (23).
Analysis of splenocytes and thymocytes from I-Aq catL / 
and catL /  mice indicated that positive selection of CD4 
T cells was severely impaired in the absence of catL (Fig. 3
B). The percentage of CD4  T cells detected in the spleen
was decreased by 65–70% in the absence of catL, as has
been observed for the I-Ab haplotype (21; Fig. 4 A). The
effect of catL on positive selection of CD4  T cells is not
dose dependent as heterozygous and wild-type littermate
control mice exhibited the same CD4  T cell profiles (data
not shown). These observations suggest that the decreased
positive selection of CD4  T cells in catL-deficient animals
is not solely due to the block in Ii degradation but that catL
has an Ii independent effect on MHC class II presentation
by cTECs, e.g., generation of peptide epitopes.
CD4  T Cell Selection Is Reduced to Background Levels in
Mice Deficient in Both Cathepsin L and Invariant Chain.
The finding that CD4  T cell selection is severely dimin-
ished in I-Aq catL /  mice suggests catL has an effect on
cTEC MHC class II peptide presentation that is indepen-
dent of its role in Ii processing. To investigate this possibil-
Figure 2. In the absence of negative selection the proportion of CD4
single-positive thymocytes is enhanced in cathepsin L–deficient mice.
Bone marrow from either BL6 or A  /  mice was transplanted into le-
thally irradiated BL6 and catL /  mice. Mice were killed 6 wk after
bone marrow transplantation and the thymi analyzed by flow cytometry
to determine the percentage of CD4 single-positive thymocytes. The av-
erage percentage of CD4 single positive thymocytes in each group of
chimeric animals is shown on a log scale. A total of three mice per group
were analyzed in two independent experiments and each experiment is
plotted separately.1353 Honey et al.
ity directly we crossed I-Ab catL /  mice with Ii /  mice.
The percentage of CD4  T cells in the spleen (Fig. 4 A)
and thymus (Fig. 4 B) of catL / Ii /  animals was reduced
almost to the level observed in MHC class II–deficient ani-
mals which were used as a negative control. In contrast, se-
lection of CD4  T cells in catL / Ii /  and catL / Ii / 
littermate controls was not completely abrogated but re-
duced by  70%, as has previously been reported (21, 25,
26). This reduction in the efficiency of selection in the ab-
sence of both catL and Ii, when compared with single
knockout littermates, indicates that these two molecules
have distinct roles in regulating positive selection.
Figure 3. Selection of CD4 
T cells is impaired in I-Aq catL-
deficient mice. (A) Thymic stro-
mal cells were isolated from I-Ab
and I-Aq catL / , catL / , and
catL /  animals and lysed in the
presence of protease inhibitors.
100  g protein lysate was immu-
noprecipitated with the I-Ab,d,q
specific Ab M5/114, precipitated
proteins were separated by 12%
SDS-PAGE and transferred to
nitrocellulose before immuno-
blotting with the Ii specific Ab
IN-1. Binding was detected
using HRP-conjugated mouse
anti–rat IgG. Ii-deficient thymic
stromal cells were treated as the
other cell samples and used as a
control for IN-1 specificity. The
data is shown as different expo-
sures of the same blot, a longer
exposure was required to clearly
visualize Ii fragments associated with I-Aq. The results shown are representative of two independent experiments. (B) Single cell suspensions of spleno-
cytes and thymocytes from I-Aq catL /  and catL /  littermates were analyzed by flow cytometry. The CD4/CD8 profiles shown are representative of
seven animals analyzed in three independent experiments.
Figure 4. Selection of CD4 
T cells is reduced to background
levels in cathepsin L x invariant
chain double-deficient mice.
Splenocytes (A) and thymocytes
(B) were isolated from catL / 
Ii / , catL / Ii / , catL / Ii / ,
and catL / Ii /  mice and ana-
lyzed by flow cytometry for
CD4 and CD8. A  /  mice
were used as a negative control
for CD4  T cell selection. The
cellularity of each thymus was
 100   106. The proportion of
double-positive thymocytes ex-
pressing CD69 was determined
by flow cytometry (C). The data
shown are representative of eight
independent experiments, each
with a minimum of one mouse
of each genotype.1354 Regulation of CD4 T Cell–positive Selection by Cathepsin L
Further analysis of these mice indicates that the early
stages of thymocyte maturation occur normally in the ab-
sence of either catL or Ii, or both, as total thymus cellular-
ity, numbers of double positive thymocytes and their level
of expression of CD69 was comparable in these mice and
wild type animals (Fig. 4, A and C). Furthermore, the pro-
portion of HSA low cells amongst the CD4 single-positive
thymocytes was the same for all the mice (data not shown).
In addition, the percentage of CD8  T cells was the same
in wild-type, catL / Ii / , and catL / Ii /  spleen and
thymus, while in MHC class II–deficient animals and
catL / Ii /  mice the percentage of these cells was in-
creased (Fig. 4, A and B).
To ensure that our results could be interpreted as indi-
cating that catL can effect cTEC MHC class II presentation
independently of its role in Ii processing, we wished to de-
termine whether expression of catL was altered by the pres-
ence or absence of Ii. Low levels of catL activity can be
detected in thymocytes (unpublished data) and thus we
analyzed catL expression in thymic stromal cells isolated
from RAG /  and RAG / Ii /  mice. CatL /  thymic
stroma was used as a negative control. Mature catL protein
could be detected in the absence of Ii at a level comparable
to that observed in Ii-sufficient cells (Fig. 5 A). Equal pro-
tein loading was confirmed by probing the same mem-
branes for actin (data not shown). To determine whether
the catL protein detected by immunoblotting was active,
thymic stromal cell lysate was incubated in the presence of
the irreversible cysteine protease inhibitor Bio-Tyr-Ala-
FMK (Fig. 5 B). There was no significant difference in the
level of catL activity detected in the presence or absence of
Ii, indicating that in thymic epithelial cells catL activity is
not substantially altered by a defect in Ii. This result differs
from a recently published report in which it was shown
that in bone marrow derived macrophages the p41 isoform
of Ii is required for catL activity (36).
To exclude the possibility that the Ii-independent effect
of catL on CD4  T cell selection was a result of altered
MHC class II levels, we analyzed the level of expression of
MHC class II molecules on catL deficient cTECs (Fig. 6).
The expression of MHC class II was decreased in the ab-
sence of Ii, as has previously been observed (25, 26), how-
ever, there was no significant difference in the level of
MHC class II expressed on the surface of wild-type and
catL /  cTECs. This observation is consistent with a previ-
ously published report in which similar levels of MHC class
II were detected on wild-type and catL /  cTECs (21) and
strongly suggests catL plays a role in determining the MHC
class II peptide repertoire responsible for CD4  T cell pos-
itive selection.
Discussion
The MHC class II peptide repertoire encountered by a
CD4  T cell in the thymus determines whether or not the
cell will be selected (2, 3). As a result, the mechanisms that
regulate MHC class II peptide generation in thymic APCs
directly impact the process of CD4  T cell selection. This
is exemplified by the observation that CD4  T cell selec-
Figure 5. Cathepsin L expression is not significantly altered in the ab-
sence of invariant chain. Thymic stromal cells were isolated from RAG / ,
RAG / Ii / , and catL /  animals and lysed in the presence of protease
inhibitors. (A) Cell lysate containing 20  g protein was reduced, sepa-
rated by SDS-PAGE in a 12% gel and the proteins electrophoretically
transferred to nitrocellulose. The membrane was probed with catL spe-
cific rabbit antiserum and binding was detected using HRP-conjugated
donkey anti-rabbit IgG. (B) Cell lysate containing 100  g protein was in-
cubated in the presence of the irreversible cysteine protease inhibitor Bio-
Tyr-Ala-FMK, reduced, separated by SDS-PAGE in a 12% gel and the
proteins electrophoretically transferred to nitrocellulose. Labeled proteins
were detected by probing the membrane with streptavidin-conjugated
HRP. These results are representative of two independent experiments.
Figure 6. Cathepsin L plays no significant role in determining the level
of expression of MHC class II on cTECs. Thymi from catL / Ii / ,
catL / Ii / , catL / Ii / , and catL / Ii /  6–8 week old mice were en-
riched for cTECs as described in the Materials and Methods. The cells
were analyzed by flow cytometry and the level of expression of MHC class II
on the surface of cTECs was determined by gating on CD11c CD4 BP-1hi
cells. The mean fluorescence intensity is shown in parenthesis. The data
shown are representative of three independent experiments.1355 Honey et al.
tion is severely impaired in Ii-deficient mice which display
a diminished repertoire of MHC class II bound peptides
(25, 26). Inefficient selection of CD4  T cells is also ob-
served in mice lacking catL (21). CatL is highly expressed
in the cells mediating positive selection, cTECs, and has
been shown to elicit the late stages of Ii degradation (21).
Cleavage of Ii is a critical event regulating peptide presen-
tation in the context of MHC class II (37, 38), and the de-
fect in CD4  T cell selection in catL /  mice is thought
largely to be mediated by altered cTEC MHC class II pre-
sentation resulting from the key role played by this protease
in Ii degradation. However, as this function of catL is so
critical for peptide presentation by I-Ab molecules it masks
other effects the enzyme may have, including any potential
role in epitope generation. We have previously attempted
to assess the repertoire of I-Ab peptides expressed by cTECs
deficient in both catL and Ii, or in Ii alone, using T cell hy-
bridomas specific for a number of self peptide–I-Ab com-
plexes (unpublished data). However, we were unable to
detect cTEC peptide presentation in this way. Therefore,
we use here the previously employed readout of CD4  T
cell selection as an indicator of thymic MHC class II–
bound peptide diversity (3, 27–29). We analyzed CD4  T
cell numbers in I-Aq catL /  mice and I-Ab mice deficient
in both catL and Ii to investigate whether the defect in
CD4  T cell selection in the absence of catL was due solely
to its role in Ii degradation. We show that in cTECs there
is much less association of the p12 fragment of Ii with I-Aq
than with I-Ab, a result consistent with our previous obser-
vations in bone marrow–derived APCs (23), indicating that
the defect in maturation of MHC class II molecules in
catL /  cTECs is haplotype dependent. We used this dif-
ference to determine that the defect in CD4  T cell selec-
tion in catL /  mice is not haplotype dependent, and thus,
by implication cannot be explained solely by impaired Ii
degradation. Analysis of I-Ab mice deficient in both catL
and Ii indicated that CD4  T cell selection was less effi-
cient in the absence of both molecules than in single
knockout animals and thus, we were able to confirm that
catL plays a role in CD4  T cell selection independently of
its effect on Ii processing.
Selection of thymocytes expressing a MHC class II–
restricted transgenic TCR was shown to be completely ab-
rogated in catL /  mice. In contrast, selection of both CD8 
TCR transgenic T cells and polyclonal CD8  T cells oc-
curred normally. These results indicate that the catL defect
in T cell selection is specific for CD4  T cells and that the
general ability of cTECs to mediate positive selection is not
impaired. The observation that thymic architecture is nor-
mal in catL deficient mice further suggests that thymic
function is not globally affected by the absence of catL (21,
39). Selection of CD4  TCR transgenic thymocytes is
completely blocked in catL /  mice while selection of
polyclonal CD4  T cells is not completely abrogated.
Therefore, we believe that it is highly unlikely that catL
regulates expression of an unknown molecule(s) required
for CD4  T cell selection, as has been suggested by others
(4), implying that the effect of catL must be mediated via
cTEC MHC class II presentation. Furthermore, we have
detected no significant difference in the levels of MHC
class II expressed at the surface of wild type and catL / 
cTECs (21; Fig. 5), indicating that the defect in CD4  T
cell selection in catL deficient mice is not a result of quanti-
tative differences in the cTEC MHC class II expression
levels. The above data provide indirect evidence of a quali-
tative difference in MHC class II presentation by catL-defi-
cient cTECs. Further support for such an assertion comes
from our results implying that an altered T cell repertoire is
selected in catL /  mice relative to BL6 controls. Thus, we
suggest that our data provide support for the hypothesis
that the defect in CD4  T cell selection observed in catL / 
mice is due to expression of an altered cTEC MHC class II
peptide repertoire.
Our data provide the first evidence that catL plays a role
in CD4  T cell selection that is distinct from its function as
the key regulator of Ii degradation in cTECs. It is therefore
likely that catL regulates the MHC class II presentation
pathway, and hence CD4  T cell selection, in several ways,
only one of which is through Ii cleavage. Taken together
with our results suggesting that the selection defect in
catL /  mice is a result of an altered MHC class II peptide
repertoire, this has lead us to propose that catL plays a di-
rect role in generating the MHC class II bound peptides in-
volved in positive selection. Although, we have not for-
mally ruled out the possibility that catL may act upon an
accessory molecule, other than Ii, involved in CD4  T cell
development, in view of the available data we consider this
unlikely. We believe therefore, that our observations imply
catL plays a direct role in generating cTEC MHC class II
peptide epitopes.
A role for catL in generating MHC class II peptide
epitopes allows the defect in CD4  T cell selection ob-
served in catL /  mice to be explained in two nonmutually
exclusive ways. In the absence of catL the diversity of the
cTEC MHC class II peptide repertoire may be diminished,
resulting in inefficient positive selection of CD4  thy-
mocytes, as has been observed in H-2M /  mice (20). In
addition, catL /  cTECs may express a novel set of peptide
epitopes which support positive selection of an altered T
cell repertoire. Such positively selected cells would then be
subject to negative selection on bone marrow–derived
APCs which express catS and not catL, and therefore, dis-
play a normal MHC class II peptide repertoire. Our obser-
vation that the increase in the proportion of CD4 single
positive thymocytes in the absence of negatively selecting
MHC class II  bone marrow–derived APCs was substan-
tially greater in catL /  mice (5–15-fold increase) than BL6
controls (2–3-fold increase), provides some evidence to
suggest that at least part of the defect in CD4  T cell selec-
tion in catL /  mice occurs as a result of positive selection
of an altered T cell repertoire. In addition, we observed
that the decrease in CD4  T cells in catL /  mice was ac-
companied by no change in the percentage of CD8  T
cells when compared with wild-type animals. In mice defi-
cient in either MHC class II or Ii the decrease in CD4  T
cells was, however, concomitant with an increase in CD8 1356 Regulation of CD4 T Cell–positive Selection by Cathepsin L
T cells. The level of MHC class II and the diversity of the
peptides expressed by these molecules is dramatically de-
creased on both positively selecting cTECs and negatively
selecting bone marrow–derived APCs in mice deficient in
Ii or MHC class II, while in catL /  mice the MHC class II
peptide repertoire is altered only on cTECs. We suggest
therefore, that in the absence of catL, any positively se-
lected thymocytes expressing MHC class II–restricted
TCRs are efficiently negatively selected by the bone mar-
row–derived APCs. In contrast, in Ii and MHC class II de-
ficient mice neither positive or negative selection can be
mediated efficiently allowing a proportion of the cells ex-
pressing MHC class II–restricted TCRs to engage MHC
class I molecules with sufficient avidity to be selected
as CD8  T cells. Similarly, both (A  /  → wt) and
(A  /  → catL / ) chimeras, mice which lack the ability
to mediate negative selection of MHC class II–restricted
thymocytes, exhibited an increase in the proportion of
CD8 single-positive thymocytes compared with animals
eliciting normal levels of negative selection (data not
shown). We suggest these data indicate that while the effi-
ciency of positive selection may be decreased in the ab-
sence of catL, a significant proportion of the defect in
CD4  T cell selection in catL-deficient mice is a result of
positive selection of an altered T cell repertoire on an al-
tered MHC class II peptide repertoire.
Expression of catL in thymic APCs is limited to cTECs,
as the bone marrow–derived APCs that mediate negative
selection express only catS (21). Therefore, as we propose
that catL plays a role in generating the peptide epitopes
bound to cTEC MHC class II molecules, it is possible that
the MHC class II peptide repertoire of the cells eliciting
positive and negative selection is not completely overlap-
ping, as has previously been suggested by others (40). The
extent to which the positively and negatively selecting pep-
tide repertoires differ is however, likely to be limited, as
our recent in vitro studies have shown that the majority of
peptides bound to MHC class II molecules isolated from a
fibroblast cell line engineered to express either catS or catL
are identical (41). A small subset of peptides regulated spe-
cifically by either catS or catL was identified, although
whether these or other disparately generated peptides are
expressed in vivo at physiologically significant levels has not
been determined. Therefore, elucidating the mechanisms
regulating MHC class II peptide generation in different
APCs is pivotal to furthering our understanding of thy-
mocyte selection.
The precise mechanisms by which MHC class II bound
peptides are generated, in distinct APCs, are ill-defined and
our data provide the first description of an enzyme regulat-
ing this process in vivo. In vitro assays using purified pro-
teases and substrates have previously indicated a role for
two other cathepsins, cathepsin D (catD) (15, 16) and
cathepsin E (17), in Ag degradation before MHC class II
presentation. Analysis of catD /  APCs, however, demon-
strated that this enzyme is dispensable for such presentation
in vivo (42, 43). Asparagine endopeptidase (AEP) has been
shown to be a key enzyme in generation of MHC class II-
bound peptides derived from the microbial Ag tetanus
toxin C (44, 45). However, the in vivo importance of this
enzyme remains to be determined.
Recently published data have shown that catL activity
in bone marrow–derived macrophages requires the pres-
ence of the p41 isoform of Ii (35). We show here, how-
ever, that in thymic stromal cells the level of mature catL
protein is not significantly decreased in the absence of Ii.
Furthermore, catL activity detected in these cells in the ab-
sence of Ii, was comparable to that in wild-type cells. Our
observation that cTEC expression of catL is not signifi-
cantly altered by the absence of Ii is consistent with previ-
ously published reports that mice lacking the p41 isoform
of Ii exhibit no defect in positive selection (46, 47). Simi-
larly, we have observed no change in the level of catL ex-
pressed in thioglycollate elicited peritoneal macrophages
isolated from Ii sufficient and deficient mice (unpublished
data). One potential explanation for the discrepancy be-
tween these data is that catL dependence upon p41 was
observed in cells differentiated to become APCs in vitro,
while no such requirement has been detected in ex vivo–
derived cells.
In conclusion, we have shown that the defect in T cell
selection in catL knockout mice is not a global effect on the
positively selecting thymic environment but that it is spe-
cific for CD4  T cells. This effect on CD4  T cell selec-
tion was not mediated by quantitative differences in the
level of MHC class II expressed by cTECs and appears to
mediate selection of an altered T cell repertoire susceptible
to extensive negative selection on bone marrow–derived
APCs; thus implicating catL as pivotal in determining qual-
itative differences in MHC class II presentation, i.e., the di-
versity of the positively selecting MHC class II peptide rep-
ertoire. The mechanism by which catL determines the
repertoire of peptides bound to MHC class II may in part
be via its role in late stage Ii degradation. However, we
show here that catL also regulates CD4  T cell selection in
an Ii independent manner, and suggest this protease may
play a direct role in generating the cTEC MHC class II
peptide epitopes eliciting positive selection.
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